• Monte Rosa Therapeutics (NASDAQ:GLUE) Earns Outperform Rating from Wedbush

    Источник: Buzz FX / 21 мар 2025 19:36:18   America/Chicago


    Monte Rosa Therapeutics (NASDAQ:GLUE) Earns Outperform Rating from Wedbush Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads Monte Rosa Therapeutics ( NASDAQ:GLUE - Get Free Report ) 's stock had its "outperfor
    Read more...
Опубликовать